 |
4-[(7-Methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)methyl]benzoic acid, hemifumarate |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-18 00:00:00 |
| Sponsor | ARMGO Pharma, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591 |
